All News

Cox-2 inhibitors carry risk for arthritis patients with heart disease.

Top news of the day from across the health care landscape.

Research evaluates sofosbuvir use in hepatitis C patients with a mental health disease.

DaxibotulinumtoxinA injection assessed for the potential management of plantar fasciitis, which is the most common cause of heel pain.

Top news of the day from across the healthcare landscape.

A New York pharmacist was convicted of narcotics and health care fraud charges on Thursday, November 10.

A study published in JAMA Psychiatry has concluded that infants born to mothers who use selective serotonin reuptake inhibitors (SSRIs) during pregnancy are at higher risk for speech and language disorders during childhood.

Revance has begun its phase 2 placebo-controlled trial for DaxibotulinumtoxinA (RT002) for injection.

The CDC has recently reported increasing antibiotic resistant Treponema pallidum strains and ocular syphilis incidence.

Top articles of the week from The American Journal of Pharmacy Benefits.

Hospital rankings may be skewed by transfer rates and treatment volumes.

A 2-year study will examine the effectiveness of advanced MRI to determine response to breast cancer treatment.

A recent review outlines the best treatment option to prevent bone loss associated with rheumatoid arthritis.

The cost of long-term care has caused some Medicare beneficiaries to spend their savings to be eligible for Medicaid services.

The companies plan to collaborate on clinical trials of a novel combination therapy for multiple myeloma.

Vietnam War veterans are more likely to contract hepatitis C virus than any other veterans, and 65-year-old Joe Benko was no exception to the statistic.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the healthcare landscape.

On election day, voters headed to the polls not only to cast their ballots for the next US President, but also, in 9 states, to determine whether to legalize or expand the use of marijuana.

Top news of the day from across the health care landscape.

Long-term oxygen treatment did not improve survival in patients with COPD with moderately low blood oxygen levels.

The Amplatzer Occluder device can reduce recurrent strokes in patients with a heart defect.

Tenofovir-alafenamide combination approved by the FDA for chronic hepatitis B infection.

Researchers develop a USB device that can detect HIV with 95% accuracy.

ACA has record-breaking day as President-elect Donald Trump promises to dismantle controverisal legislation.

Investigational drug combines a citrate anticoagulant and a renal replacement solution.

According to the CDC, 4175 cases of Zika virus infections have been reported in the United States. So far, no vaccine exists to prevent the virus, but vaccine candidates are in the works.

Chronic diseases in the United States have a tremendous economic burden. Thirty-four percent of the economic burden of diabetes is attributed to the privately insured population.

Baxter has begun a phase 3 clinical trial for an investigational drug that combines a citrate anticoagulant and a renal replacement solution.

On November 10, 2016, Michigan State Representatives introduced HB 6045, which would amend the Michigan Public Health Code to provide restrictions on the quantity of prescription opioid medications that can be issued by a prescriber under certain circumstances. This legislation comes on the heels of recent efforts by the CDC to raise awareness and hopefully curtail the growing opioid epidemic.